Skip to content

Contralateral Transcutaneous electrical nerve stimulation (TENS) for phantom limb pain, A prospective randomized controlled trial (CTEP trial)

Contralateral Transcutaneous electrical nerve stimulation (TENS) for phantom limb pain, A prospective randomized controlled trial (CTEP trial)

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220722001
Enrollment
120
Registered
2022-07-22
Start date
2021-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic phantom limb pain patients Contralateral Transcutaneous electrical nerve stimulation (TENS) phantom limb pain randomized controlled trial

Interventions

Participants assigned to the TENS condition will be administered TENS on the contralateral limb (TENS setting: pulse width 80 ms, frequency 100 Hz, and intensity depends on the patient response but th
Experimental Device,Placebo Comparator Device
TENS ,Placebo

Sponsors

Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age more than 18 years. 2. Able to use the 0-10 Numerical Rating Scale (NRS) to rate pain intensity. 3. Patient has phantom limb pain with an average intensity in the past week greater than equal 3 on a 0-10 NRS. 4. Duration of phantom limb pain more than 3 months

Exclusion criteria

Exclusion criteria: 1. Patients cannot understand or express themselves in Thai. 2. Serious psychiatric problem (such as schizophrenia or suicidal ideation with intent) that would interfere with study participation. 3. Contraindicated to receive TENS treatment (e.g., patient with a pace maker, patient spinal cord stimulation or LVAD). 4. Unable to apply TENS at the contralateral limb. 5. Other primary pain conditions or secondary pain associated with other diagnoses such as cancer or severe RLP (i.e., RLP with a greater average severity than PLP). However, although individuals with RLP that is greater in severity than PLP will be excluded from participating in the primary trial, these individuals may be enrolled in the study as RLP participants to pilot the effects of contralateral limb TENS in these individuals.

Design outcomes

Primary

MeasureTime frame
Pain intensity at 14 days of home use of the TENS machine Numeric rating scale

Secondary

MeasureTime frame
Pain interference at 14 days of home use of the TENS machine PROMIS-29 Thai,Pain interference at 14 days of home use of the TENS machine Neuropathic Pain Symptom Inventory (NPSI Thai),Quality of life at 14 days of home use of the TENS machine Euroqol 5D5L- Thai

Countries

Thailand

Contacts

Public ContactNanticha Kessava

Faculty of Medicine Siriraj Hospital, Mahidol University

nanticha.kes@gmail.com0944142645

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026